Senior MSL - Oncology & Rare Disease Specialist

Openwork; New York (NY); On-site; USD 185,000 - 230,000; Full time

Job summary

Openwork is seeking a Medical Science Liaison/Senior MSL to join our field-based medical team supporting oncology and rare disease. This role focuses on building relationships with hospital-based clinicians, providing scientific data, and maintaining expertise across uro-oncology and rare diseases.

Travel across the US and international sites is expected, with annual salary in the six-figure range. The candidate will develop territory plans, support clinical trials, and train new MSLs while

Qualifications

• Advanced clinical/science degree or professional credentials required.
• 5+ years in biotech, startup or pharma, with 3+ years MSL experience and cross-functional collaboration.
• Oncology and rare disease experience preferred.
• Experience in hospital/institutional/clinical/pharmacy settings.

Responsibilities

• Identify engage with hospital-based clinicians and researchers to understand scientific needs.
• Provide evidence-based data and up-to-date guidelines to hospital staff.
• Develop and maintain scientific expertise in rare disease/uro-oncology portfolio through ongoing training and conferences.
• Build territory plans for geographies, engaging HCPs/KOLs at institutions and conferences.
• Support clinical trial execution including recruitment and site outreach; communicate feedback to Clinical Ops/Development.

Skills

MSL experience

Interpersonal skills

Analytical skills

Travel readiness

Education

MD/DO/PhD/PharmD/PA/NP/RN

Job description

Openwork is seeking a Medical Science Liaison/Senior MSL to join our field-based medical team supporting oncology and rare disease. This role focuses on building relationships with hospital-based clinicians, providing scientific data, and maintaining expertise across uro-oncology and rare diseases.

Travel across the US and international sites is expected, with annual salary in the six-figure range. The candidate will develop territory plans, support clinical trials, and train new MSLs while